Precision Health Program, Michigan State University, East Lansing, MI, USA.
Depatment of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Nat Commun. 2024 Nov 7;15(1):9638. doi: 10.1038/s41467-024-53966-z.
The protein corona formed on nanoparticles (NPs) has potential as a valuable diagnostic tool for improving plasma proteome coverage. Here, we show that spiking small molecules, including metabolites, lipids, vitamins, and nutrients into plasma can induce diverse protein corona patterns on otherwise identical NPs, significantly enhancing the depth of plasma proteome profiling. The protein coronas on polystyrene NPs when exposed to plasma treated with an array of small molecules allows for the detection of 1793 proteins marking an 8.25-fold increase in the number of quantified proteins compared to plasma alone (218 proteins) and a 2.63-fold increase relative to the untreated protein corona (681 proteins). Furthermore, we discovered that adding 1000 µg/ml phosphatidylcholine could singularly enable the detection of 897 proteins. At this specific concentration, phosphatidylcholine selectively depletes the four most abundant plasma proteins, including albumin, thus reducing the dynamic range of plasma proteome and enabling the detection of proteins with lower abundance. Employing an optimized data-independent acquisition approach, the inclusion of phosphatidylcholine leads to the detection of 1436 proteins in a single plasma sample. Our molecular dynamics results reveal that phosphatidylcholine interacts with albumin via hydrophobic interactions, H-bonds, and water bridges. The addition of phosphatidylcholine also enables the detection of 337 additional proteoforms compared to untreated protein corona using a top-down proteomics approach. Given the critical role of plasma proteomics in biomarker discovery and disease monitoring, we anticipate the widespread adoption of this methodology for the identification and clinical translation of biomarkers.
纳米颗粒(NPs)表面形成的蛋白质冠具有作为改进血浆蛋白质组覆盖的有价值的诊断工具的潜力。在这里,我们表明,将小分子(包括代谢物、脂质、维生素和营养素)掺入血浆中可以诱导原本相同的 NPs 上形成不同的蛋白质冠图案,从而显著提高血浆蛋白质组分析的深度。当暴露于用一系列小分子处理的血浆中的聚苯乙烯 NPs 上的蛋白质冠时,可以检测到 1793 种蛋白质,与单独的血浆(218 种蛋白质)相比,定量蛋白质的数量增加了 8.25 倍,与未处理的蛋白质冠(681 种蛋白质)相比,增加了 2.63 倍。此外,我们发现添加 1000µg/ml 磷脂酰胆碱可以单独检测到 897 种蛋白质。在这个特定的浓度下,磷脂酰胆碱选择性地耗尽四种最丰富的血浆蛋白质,包括白蛋白,从而降低了血浆蛋白质组的动态范围,并使低丰度蛋白质的检测成为可能。采用优化的数据独立采集方法,在单个血浆样本中加入磷脂酰胆碱可检测到 1436 种蛋白质。我们的分子动力学结果表明,磷脂酰胆碱通过疏水相互作用、氢键和水桥与白蛋白相互作用。与未处理的蛋白质冠相比,添加磷脂酰胆碱还可以通过自上而下的蛋白质组学方法检测到 337 种额外的蛋白质异构体。鉴于血浆蛋白质组学在生物标志物发现和疾病监测中的关键作用,我们预计这种方法将被广泛用于鉴定和临床转化生物标志物。